Integrated Research Limited (IRI) AI Stock Analysis

• Market Cap: $65.92M
• Dividend Yield: 5.48%
• Average Volume (3M): 234.26K
• Price to Earnings (P/E): 4.8
• Beta (1Y): 0.86
• Revenue Growth: -18.05%
• EPS Growth: -51.45%
• Country: AU
• Employees: 142
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.05
• Shares Outstanding: 180,591,800
• 10 Day Avg. Volume: 196,193
• 30 Day Avg. Volume: 234,256
• PEG Ratio: -0.11
• Price to Book (P/B): 0.74
• Price to Sales (P/S): 1.09
• P/FCF Ratio: 9.12
• Enterprise Value/Market Cap: 0.55
• Enterprise Value/Revenue: 0.53
• Enterprise Value/Gross Profit: 0.71
• Enterprise Value/Ebitda: 2.68
• 1Y Price Target: $0.52
• Price Target Upside: 41.32% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 62 Neutral
• Price Target: AU$0.50 ▲(35.14% Upside)

Integrated Research Limited's stock score is primarily influenced by its strong valuation metrics, including a low P/E ratio and high dividend yield. However, the score is moderated by bearish technical indicators and mixed financial performance, with declining revenue and profitability margins posing significant risks.

Integrated Research Limited Business Overview & Revenue Model

Company Description

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services, as well as software as a service solution. The company offers its products in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturers. The company was incorporated in 1988 and is based in North Sydney, Australia.

How the Company Makes Money

Integrated Research Limited generates revenue primarily through the sale of its Prognosis software solutions, which are offered via perpetual licenses, subscription models, and cloud-based services. The company also earns money from maintenance and support services provided to its clients. Key revenue streams include licensing fees, subscription fees, and service contracts. IRI's business model is supported by strategic partnerships with major IT and communications firms, which help expand its market reach and enhance its product offerings. Additionally, the company invests in research and development to continuously innovate and maintain its competitive edge in the performance management industry.

Integrated Research Limited Financial Statement Overview

Summary

Integrated Research Limited has shown significant financial improvement, with strong revenue growth, improved profit margins, and enhanced operational efficiency. The balance sheet is solid with low leverage and high equity utilization, though cash flow growth sustainability needs attention.

Income Statement

Integrated Research Limited has shown strong recovery with a notable revenue growth of 19.3% this year. The company has achieved a gross profit margin of 100%, and a remarkable improvement in net profit margin from -41.8% to 32.6%. EBIT and EBITDA margins have also turned positive, indicating enhanced operational efficiency.

Balance Sheet

The balance sheet reflects a solid equity position with an equity ratio of 77.4%. The debt-to-equity ratio is low at 0.02, indicating minimal leverage. Return on Equity (ROE) improved significantly to 30.7%, reflecting effective use of equity to generate profits.

Cash Flow

Operating cash flow remains strong, although slightly down from the previous year. The free cash flow has almost doubled, leading to a free cash flow to net income ratio of 0.56, showcasing solid cash generation capabilities. However, the operating cash flow to net income ratio decreased to 0.56.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	68.26M	68.26M	83.29M	69.83M	62.87M	78.49M
Gross Profit	50.68M	68.26M	83.29M	28.94M	62.87M	78.49M
EBITDA	13.45M	13.45M	25.34M	-1.07M	10.40M	23.21M
Net Income	13.36M	13.36M	27.13M	-29.23M	1.54M	7.93M
Balance Sheet
Total Assets	122.97M	122.97M	114.19M	90.84M	132.20M	136.63M
Cash, Cash Equivalents and Short-Term Investments	40.59M	40.59M	31.89M	18.55M	12.33M	12.15M
Total Debt	1.85M	1.85M	1.72M	3.05M	4.87M	13.08M
Total Liabilities	22.36M	22.36M	25.82M	30.97M	45.08M	53.29M
Stockholders Equity	100.62M	100.62M	88.36M	59.87M	87.11M	83.34M
Cash Flow
Free Cash Flow	8.18M	8.18M	15.22M	8.20M	6.97M	9.67M
Operating Cash Flow	8.68M	8.68M	13.04M	15.99M	18.76M	21.91M
Investing Cash Flow	1.17M	4.12M	2.27M	-8.90M	-11.80M	-12.24M
Financing Cash Flow	-4.90M	-5.00M	-1.69M	-1.63M	-6.96M	-6.44M

Integrated Research Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.37
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IRI, the sentiment is Negative. The current price of 0.37 is below the 20-day moving average (MA) of 0.38, below the 50-day MA of 0.41, and below the 200-day MA of 0.41, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 40.07 is Neutral, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IRI.

Integrated Research Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IRI	62 Neutral	$65.92M	4.83	13.76%	5.48%	-18.05%	-51.45%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
FLX	49 Neutral	AU$65.30M	―	-1801.55%	―	21.82%	6.83%
AMX	46 Neutral	AU$18.52M	―	-31.01%	―	-3.43%	-40.65%
PRO	41 Neutral	AU$15.12M	―	-133.07%	―	-4.90%	-52.78%
NVU	35 Underperform	AU$81.43M	―	-243.28%	―	―	―

Integrated Research Limited Corporate Events

Integrated Research Limited Reports FY25 Trading Update and Strategic Shift

Integrated Research Limited has announced its FY25 full-year trading update, highlighting a transition towards a product-led growth strategy. Despite a softer renewals book impacting total contract value and statutory revenue, the company saw a stronger second half performance. Key achievements included securing a significant five-year contract with JP Morgan Chase and launching the High Value Payments product with a top 10 US bank as the first client. The company also introduced the IR Hosted Prognosis product, marking a shift towards a consumption-based SaaS model. Looking ahead, Integrated Research plans to launch AI-powered product capabilities in FY26, aiming to drive sustainable growth and innovation.

The most recent analyst rating on (AU:IRI) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.